PMID: 8970946Dec 1, 1996Paper

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Journal of Virology
J H CondraE A Emini

Abstract

Indinavir (IDV) (also called CRIXIVAN, MK-639, or L-735,524) is a potent and selective inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease. During early clinical trials, in which patients initiated therapy with suboptimal dosages of IDV, we monitored the emergence of viral resistance to the inhibitor by genotypic and phenotypic characterization of primary HIV-1 isolates. Development of resistance coincided with variable patterns of multiple substitutions among at least 11 protease amino acid residues. No single substitution was present in all resistant isolates, indicating that resistance evolves through multiple genetic pathways. Despite this complexity, all of 29 resistant isolates tested exhibited alteration of residues M-46 (to I or L) and/or V-82 (to A, F, or T), suggesting that screening of these residues may be useful in predicting the emergence of resistance. We also extended our previous finding that IDV-resistant viral variants exhibit various patterns of cross-resistance to a diverse panel of HIV-1 protease inhibitors. Finally, we noted an association between the number of protease amino acid substitutions and the observed level of IDV resistance. No single substitution or pair of substitutions test...Continue Reading

References

Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·N E KohlI S Sigal
Jun 1, 1995·AIDS Research and Human Retroviruses·J EberleH Nitschko
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·D J KempfX P Kong
Oct 1, 1994·Biopharmaceutics & Drug Disposition·Y N WongS M Huang
Oct 14, 1994·Journal of Medicinal Chemistry·B D DorseyJ C Quintero
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·J P VaccaE Roth
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·A H KaplanR Swanstrom
Oct 1, 1995·Antimicrobial Agents and Chemotherapy·M BryantK Houseman
Jun 15, 1996·Annals of Internal Medicine·J M SchapiroT C Merigan

❮ Previous
Next ❯

Citations

Jan 13, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S A Locarnini
Aug 15, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·M J PazzaniJ Tilles
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·W K WangT H Lee
Mar 19, 1999·AIDS Research and Human Retroviruses·M VaillancourtR Swanstrom
Aug 14, 1999·The Journal of Biological Chemistry·D B OlsenL C Kuo
Jun 22, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E P AcostaC V Fletcher
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·J Martinez-PicadoR T D'Aquila
Oct 6, 2000·AIDS Research and Human Retroviruses·P B GilbertR T D'Aquila
May 24, 2000·Journal of Clinical Pathology·M Helbert, J Breuer
Nov 30, 2000·Current Infectious Disease Reports·G J Hanna, R T D'Aquila
Jun 1, 2001·Nature Medicine·C A StoddartJ M McCune
Sep 15, 2001·Antimicrobial Agents and Chemotherapy·A J SaahP J Deutsch
Aug 16, 2002·European Journal of Biochemistry·Anita FehérJózsef Tözsér
Jun 25, 2002·AIDS Research and Human Retroviruses·Anna PapaAntonis Antoniadis
Aug 5, 2003·Statistics in Medicine·A S Foulkes, V DeGruttola
Nov 15, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Matthew J GonzalesRobert W Shafer
Aug 11, 2005·Current HIV/AIDS Reports·Joel E Gallant
Jun 29, 2006·Clinical Pharmacokinetics·Jennifer R King, Edward P Acosta
May 9, 2008·AIDS Research and Human Retroviruses·Jeffrey A AndersonUNKNOWN AIDS Clinical Trials Group Study 359 Protocol Team
Nov 28, 2007·PLoS Computational Biology·Art F Y PoonSimon D W Frost
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·Soo-Yon RheeRobert W Shafer
Nov 26, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sandra M MuellerUNKNOWN German Competence Network for HIV/AIDS
Dec 15, 2010·Antimicrobial Agents and Chemotherapy·Chris M ParryDeenan Pillay
Feb 11, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shanmugam SaravananSuniti Solomon
Feb 13, 2013·AIDS Research and Human Retroviruses·Maria Cecilia A SucupiraRicardo Sobhie Diaz
Jul 8, 2015·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Julia HillungSantiago F Elena
Mar 18, 2016·PloS One·Zsigmond BenkoRichard Y Zhao
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·J H Condra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.